增生型糖尿病视网膜病变患者玻璃体中的补体激活
该研究采集伴或不伴增生型糖尿病视网膜病变(PDR)患者的血浆与玻璃体样本,测定16种补体成分及白蛋白水平,并以局部与全身补体、白蛋白的归一化比值校正血管渗漏。归一化后PDR眼C4、B因子和C5水平低于对照,C3a和Ba水平高于对照,C3a/C3、C5a/C5和Ba/B因子比值升高,提示眼内C3、C5和B因子局部激活及替代途径参与。
要点
- 归一化后PDR眼C3a、Ba升高,C4、B因子、C5降低。
- PDR眼C3a/C3、C5a/C5、Ba/B因子比值均高于对照。
- 结果提示眼内存在C3、C5和B因子的局部激活。
核心结论
- 研究提示PDR患者眼内存在C3、C5和B因子的局部激活,归一化数据提示替代补体途径参与,并据此提出诊断与治疗潜在靶点。
研究设计与样本
- 研究纳入伴或不伴增生型糖尿病视网膜病变(PDR)的患者,采集血浆和玻璃体样本进行检测。
- 测定16种补体成分及白蛋白水平,并采用局部与全身补体、白蛋白水平的归一化比值校正玻璃体腔血管渗漏。
主要发现
- 归一化前,PDR眼所测16种补体成分水平均显著高于对照。
- 归一化后,PDR眼C4、B因子和C5水平低于对照,C3a和Ba水平高于对照。
- 归一化后,PDR眼C3a/C3、C5a/C5和Ba/B因子比值高于对照。
临床怎么用
- 解读玻璃体补体数据时需用局部与全身补体、白蛋白归一化比值校正血管渗漏的影响。
- C3a/C3、C5a/C5和Ba/B因子比值变化可作为评估眼内补体激活的参考指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: A growing body of evidence points to complement dysregulation in diabetes. Early studies have indicated the presence of complement components inside the eye in patients with diabetic retinopathy, but these data have been confounded by leakage of proteins from the systemic circulation into the vitreous cavity. METHODS: We took samples of plasma and vitreous from patients with and without proliferative diabetic retinopathy (PDR) and measured levels of 16 complement components as well as albumin. We employed a normalized ratio using local and systemic complement and albumin levels to control for vascular leakage into the vitreous cavity. RESULTS: Before normalizing, we found significantly higher levels of 16 complement components we measured in PDR eyes compared to controls. After normalizing, levels of C4, factor B, and C5 were decreased compared to controls, while C3a and Ba levels were elevated compared to controls. We also found higher ratios of C3a/C3, C5a/C5, and Ba/factor B in PDR eyes compared to controls. CONCLUSIONS: We found evidence of local, intraocular activation of C3, C5, and factor B. The normalized data suggest involvement of the alternative complement pathway. By showing activation of specific complement components in PDR, this study identifies targets for diagnostic and therapeutic potential.
引用
- Mandava N, Tirado-Gonzalez V, Geiger MD, et al. Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2020. PMID: 32965482. doi:10.1167/iovs.61.11.39
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。